Where Does Plus Therapeutics Inc (PSTV) Stock Fall in the Biotechnology Field After It Has Risen 62.33% This Week?

A rating of 82 puts Plus Therapeutics Inc (PSTV) near the top of the Biotechnology industry according to InvestorsObserver. Plus Therapeutics Inc's score of 82 means it scores higher than 82% of stocks in the industry. Plus Therapeutics Inc also received an overall rating of 64, putting it above 64% of all stocks. Biotechnology is ranked 47 out of the 148 industries.

PSTV has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on PSTV!

See Full PSTV Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Plus Therapeutics Inc Stock Today?

Plus Therapeutics Inc (PSTV) stock is down -9.89% while the S&P 500 is up 0.28% as of 9:57 AM on Monday, Nov 20. PSTV has fallen -$0.26 from the previous closing price of $2.63 on volume of 126,280 shares. Over the past year the S&P 500 has risen 14.60% while PSTV has fallen -65.65%. PSTV lost -$6.18 per share the over the last 12 months. Click Here to get the full Stock Report for Plus Therapeutics Inc stock.